期刊文献+

中草药对结核分枝杆菌生物膜的干预 被引量:2

Intervention of Chinese Herbal Medicine on Biofilm of Mycobacterium Tuberculosis
下载PDF
导出
摘要 结核病(TB)是由结核分枝杆菌(MTB)引起的传染性疾病,治疗时间长是结核防控面临的主要问题。结核杆菌能形成生物膜后,对抗结核药物的敏感性下降,因此,干预结核杆菌生物膜是治疗结核的新思路。本试验随机选择了11种中草药,评价其对结核杆菌生物膜的干预作用,结果表明,苦参(0.4 mg/ml)能抑制结核杆菌生物膜的形成,山茱萸(0.4、0.8、1.6、3.2、6.4 mg/ml)能促进结核杆菌生物膜的形成,并呈明显的量效关系。研究结果提示,不同中草药对结核杆菌生物膜的形成存在不同的干预结果。进一步开展活性跟踪研究,将为发现干预结核杆菌生物膜的分子骨架奠定基础。 Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (MTB). Long treatment time is the main problem for TB prevention and control. Mycobacterium tuberculosis can form biofilm, which could decrease bactericidal activity of anti-tuberculosis drugs. Therefore, the intervention of Mycobacterium tuberculosis biofilm is a new idea for the treatment of tuberculosis. Eleven Chinese herbs were randomly selected to evaluate their interventional effect on the formation of Mycobacterium tuberculosis biofilm. The results showed that Sophora flavescens (0.4 mg/ml) could inhibit the formation of Mycobacterium tuberculosis biofilm, and Cornus officinalis (0.4, 0.8, 1.6, 3.2, 6.4 mg/ml) could promote the formation of Mycobacterium tuberculosis biofilm and showed a dose-effect relationship. The results showed that different Chinese herbal medicine had different effect on the formation of Mycobacterium tuberculosis biofilm. Further study by bioassay guided isolation will lay the foundation for the discovery of the molecular skeleton with the interventional effect on formation of Mycobacterium tuberculosis biofilm.
机构地区 贵州大学药学院
出处 《药物化学》 2017年第3期45-51,共7页 Hans Journal of Medicinal Chemistry
基金 国家自然科学基金(81460531) 贵州省社会发展科技攻关项目(SY字[2013]3058号) 贵大SRT字(2015)075号。
  • 相关文献

参考文献5

二级参考文献128

  • 1李睿明.抗感染治疗新靶点——细菌生物膜[J].医学与哲学(B),2006,27(4):42-44. 被引量:16
  • 2陈伟忠,张俊平,许青,胡振林,谢渭芬,张兴荣,马述春,胡和平,张贤康.苦参碱对大鼠实验性肝纤维化的影响[J].第二军医大学学报,1996,17(5):424-426. 被引量:116
  • 3林文,张俊平,胡振林,钱定华.苦参碱对细菌脂多糖诱导大鼠枯否细胞释放肿瘤坏死因子及白细胞介素-6的影响[J].药学学报,1997,32(2):93-96. 被引量:68
  • 4World Health Organization. Tuberculosis MDR-TB & XDR-TB 2011 progress report[ EB/OL]. (2011-03-23) [2011-11-25 ]. http ://www. who. int/tb/challenges/mdr/factsheet _ mdr_ progress_march2011, pdf.
  • 5Boshoff HIM, Barry CE. Tuberculosis-metabolism and respiration in the absence of growth[J]. Nat Rev Microbiol,2005,3( 1 ) :70 - 80.
  • 6Munoz-Elias EJ, McKinney JD. Carbon metabolism of intracellular bacteria[ J]. Cell Microbiol,2006,8( 1 ) :10 -22.
  • 7Munoz-Elias EJ, McKinney JD. Mycobacterium tuberculosis isocitrate lyase 1 and 2 are jointly required for in vitro growth and virulence[ J]. Nat Med,2005,11(6) :638 -644.
  • 8Gould TA, Langemheen HVD, Munoz-Elias E J, et al. Dual role of isocitrate lyase 1 in the glyoxylate and methylcitrate cycles in Mycobacterium tuberculosis [ J ]. Mol Microbiol,2006 ,61 (4) : 940 - 947.
  • 9Sriram D,Yogeeswari P, Senthilkumar P, et al. Novel pthalazinyl derivatives : synthesis, antimycobacterial activities, and inhibition of Mycobacterium tuberculosis isocitrate lyase enzyme [ J ]. Med Chem,2009,5(5 ) :422 -433.
  • 10Parish T, Stoker NG. The common aromatic amino acid biosynthesis pathway is essential in Mycobacterium tuberculosis [ J ]. Microbiology, 2002,148 ( 10 ) : 3 069 - 3 077.

共引文献82

同被引文献14

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部